Baron Funds Comments on Questcor Pharmaceuticals Inc.

Author's Avatar
Dec 07, 2012
Shares of Questcor Pharmaceuticals, Inc. (QCOR, Financial) were the biggest detractor in the quarter.The company sells a single drug for which it has expanded applications to drive rapid growth. Our research uncovered some red flags which led us to sell out of our position in the quarter. Subsequent to our exit, the stock fell significantly, so I credit our work and instinct for avoiding a bigger loss.

From Baron Funds third quarter letter.